Aims. Glenoid bone loss can be a challenging problem when revising
a shoulder arthroplasty. Precise pre-operative planning based on
plain radiographs or CT scans is essential. We have investigated
a new radiological
Aims. Classifying trochlear dysplasia (TD) is useful to determine the treatment options for patients suffering from patellofemoral instability (PFI). There is no consensus on which
Aims. This study aimed to evaluate the clinical application of the PJI-TNM
Aims. The Coronal Plane Alignment of the Knee (CPAK)
Aims. The aim of this modified Delphi process was to create a structured Revision Hip Complexity
Aims. Trochlear dysplasia is a significant risk factor for patellofemoral instability. The Dejour
Aims. The aim of this study was to investigate the relationship between the Orthopaedic Trauma Society (OTS)
Aims. The evidence demonstrating the superiority of early MRI has led to increased use of MRI in clinical pathways for acute wrist trauma. The aim of this study was to describe the radiological characteristics and the inter-observer reliability of a new MRI based
Aims. To describe a new objective
Aims. The morphology of medial malleolar fracture is highly variable and difficult to characterize without 3D reconstruction. There is also no universally accepeted
Aims. The Oswestry-Bristol
Objectives. The aim of this study was to assess the clinical application of, and optimize the variables used in, the BACH
Aims. A comprehensive
The Unified
Aims. The aim of this study was to assess the prognostic value of the modified three-group Stulberg
Aims. Patients with spinal pathology who undergo total hip arthroplasty (THA) have an increased risk of dislocation and revision. The aim of this study was to determine if the use of the Hip-Spine
Aims. Iliosacral sarcoma resections have been shown to have high rates of local recurrence (LR) and poor overall survival. There is also no universal
Aims. The Wrightington
There is good scientific rationale to support the use of growth factors to promote musculoskeletal tissue regeneration. However, the clinical effectiveness of platelet-rich plasma (PRP) and other blood-derived products has yet to be proven. Characterization and reporting of PRP preparation protocols utilized in clinical trials for the treatment of musculoskeletal disease is highly inconsistent, and the majority of studies do not provide sufficient information to allow the protocols to be reproduced. Furthermore, the reporting of blood-derived products in orthopaedics is limited by the multiple PRP
Objectives. Using a simple